With 60% Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Boasts of Strong Institutional Backing
Vir Biotechnology Names Jason O'Byrne Finance Chief
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
Truist Financial analyst Jailendra Singh initiates coverage on $Caribou Biosciences(CRBU.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 35.0% and a total
Caribou Biosciences Announces CFO Resignation and Succession Plan
Express News | Caribou Biosciences- Plans to Appoint Ryan Fischesser to Assume Role of Principal Accounting Officer, Effective as Close of Business on Sept 27
Express News | Caribou Biosciences Inc - on Sept 1 Jason O'byrne, CFO, Informed of Intent to Resign From Position